Axa
RGEN icon

Axa’s Repligen RGEN Stock Holding History

Axa’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,201
Closed -$589K – 1117
2024
Q1 		$589K Buy
3,201
+153
+5% +$29.1K ﹤0.01% 918
2023
Q4 		$548K Buy
+3,048
New +$474K ﹤0.01% 929
2022
Q4 		– Sell
-16,200
Closed -$3.03M – 1208
2022
Q3 		$3.03M Buy
+16,200
New +$3.42M 0.01% 685
2022
Q2 		– Sell
-34,600
Closed -$6.51M – 1195
2022
Q1 		$6.51M Sell
34,600
-2,400
-6% -$456K 0.02% 577
2021
Q4 		$9.8M Buy
37,000
+3,000
+9% +$808K 0.03% 496
2021
Q3 		$9.83M Sell
34,000
-6,900
-17% -$1.77M 0.03% 502
2021
Q2 		$8.16M Buy
40,900
+14,500
+55% +$2.81M 0.02% 573
2021
Q1 		$5.13M Sell
26,400
-7,800
-23% -$1.6M 0.02% 702
2020
Q4 		$6.55M Buy
34,200
+1,400
+4% +$255K 0.02% 633
2020
Q3 		$4.84M Sell
32,800
-3,500
-10% -$500K 0.02% 633
2020
Q2 		$4.49M Buy
36,300
+22,900
+171% +$2.69M 0.02% 650
2020
Q1 		$1.29M Buy
+13,400
New +$1.29M 0.01% 813
2019
Q4 		– Sell
-5,600
Closed -$429K – 1293
2019
Q3 		$429K Buy
+5,600
New +$490K ﹤0.01% 1122
2019
Q2 		– Sell
-4,400
Closed -$260K – 1343
2019
Q1 		$260K Sell
4,400
-4,100
-48% -$236K ﹤0.01% 1223
2018
Q4 		$448K Buy
+8,500
New +$499K ﹤0.01% 1104
2016
Q1 		– Sell
-2,700
Closed -$76K – 1394
2015
Q4 		$76K Buy
+2,700
New +$77.9K ﹤0.01% 1268
2015
Q1 		– Sell
-42,100
Closed -$834K – 1478
2014
Q4 		$834K Buy
42,100
+36,600
+665% +$818K ﹤0.01% 1005
2014
Q3 		$110K Buy
+5,500
New +$116K ﹤0.01% 1292
2013
Q4 		– Sell
-1,500
Closed -$17K – 1422
2013
Q3 		$17K Sell
1,500
-31,037
-95% -$309K ﹤0.01% 1239
2013
Q2 		$268K Buy
+32,537
New +$273K ﹤0.01% 1071

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Axa's RGEN Position: Q2 2024 in Review

Axa sold out of Repligen (RGEN) in Q2 2024, closing a stake of 3,201 shares — an estimated $589K sold.

Axa first reported a position in RGEN in Q2 2013 and held it in 20 quarters. The position peaked at $9.83M in Q3 2021. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Axa reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Axa sold 3,201 Repligen shares in Q2 2024, an estimated $589K.
  • Axa first reported a position in Repligen in Q2 2013 and held it in 20 quarters.
  • Axa's Repligen position peaked at $9.83M in Q3 2021.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.